gobal chemicals trading platform prosessional chemical database
look for chemicals? Go >
Sign In
|
Join Free
|
Details
|
PDF
|
Products
|
Make Me Home Page
|
Add to favorite
Products
Details
PDF
About Us
Current position:
Home
>
Products
>
Lunacalcipol
Lunacalcipol
CAS Registry Number:
250384-82-8
Synonyms:
Lunacalcipol;CTA018;250384-82-8;CTA-018;UNII-XN4TL6M50Z;Lunacalcipol [USAN];Lunacalcipol [USAN:INN];XN4TL6M50Z;CTA 018;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulfonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-(1S,3R)-25-nor-25-t-Butylsulfonyl-9,10-seco-5,7,10(19),16,23- cholestapentaene-1,3-diol;1,3-Cyclohexanediol, 5-((2E)-2-((3aS,7aS)-1-((1R,3E)-4-((1,1-dimethylethyl)sulfonyl)-1- methyl-3-buten-1-yl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4- ylidene)ethylidene)-4-methylene-, (1R,3S,5Z)-;Lunacalcipol (USAN/INN);LUNACALCIPOL [INN];D00DYK;LUNACALCIPOL [WHO-DD];CHEMBL2105705;GTPL11382;CHEBI:177662;CTA018/MT2832;BDBM50023361;AKOS040752736;MT-2832;D09928;Q27293916;Lunacalcipol (intravenous, secondary hyperparathyroidism);CTA-018 (intravenous, secondary hyperparathyroidism), Cytochroma;Lunacalcipol (intravenous, secondary hyperparathyroidism), Cytochroma;CYP24 inhibitors (intravenous, secondary hyperparathyroidism), Johns Hopkins/Cytochroma;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-24-((1,1-Dimethylethyl)sulfonyl)-9,10-secochola-5,7,10(19),16,23- pentaene-1alpha,3beta-diol
Molecular Formula:
C28H42O4S
Molecular Weight:
474.7
EINECS:
Melting Point:
Solubility:
The Complete List of Suppliers for Lunacalcipol
Hot Products
N-[(3-nitrophenyl)methylideneamino]-2-[[(3-nitrophenyl)methylideneamin o]carbamoylmethyl-nitroso-amino]acetamide
Amides, C3-24, N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N-methyl
[2,9'-Bianthracene]-4',8(1'H,5H)-dione,2',3',6,7-tetrahydro-1,2',5',6,9,10'-hexahydroxy-3,7'-dimethoxy-2',6-dimethyl-,(2R,2'R,6R)- (9CI)
1(2H)-Naphthalenone,4-[2-[2-(1,2-dihydroxyethyl) oxiranyl]-2-hydroxyethyl]-3,4,4a,5,6,8ahexahydro- 2-hydroxy-3,4,8,8a-tetramethyl-
2-amino-4-(4-ethoxyphenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
Phosphorothioic acid, O-(4-bromo-2,5-dichlorophenyl) O,O-dimethyl ester, mixt. with pyrethrins
Ethylhexyl acrylate, methyl methacrylate, hydroxypropyl methacrylate, acrylic acid, acrylonitrile polymer
Benzonitrile,4-(4-propylbicyclo[2.2.2]oct-1-yl)-
8-hydroxy-3-methyl-isochroman-1-one
Chromate(2-), (2-((3-chloro-2-hydroxy-5-nitrophenyl)azo)-4-methyl-1-naphthalenolato(2-))(3-hydroxy-4-((2-hydroxy-1-naphthalenyl)azo)-1-naphthalenesulfonato(3-))-, sodium
b-Alanine, N,N-bis(2-aminoethyl)-,N,N'-disoya acyl derivs.
(2E)-3-[4-(oxidobromanyl)phenyl]-1-phenylprop-2-en-1-one
3,7-dimethyloct-6-enyl 4-methylvalerate
4-[(4-{[4-(2,5-dimethyl-1H-pyrrol-1-yl)phenyl]sulfonyl}phenyl)amino]-4-oxobutanoic acid
Fe(III)-alpha,alpha,alpha,beta-tetra-ortho-(N-methyl-isonicotinamidophenyl)porphyrin
1-(2,4-Dimethylphenyl)ethanol
About us
|
Service
|
Link
|
Add to favorite
©2010 EaseChem.com
![250384-82-8,Lunacalcipol,Lunacalcipol;CTA018;250384-82-8;CTA-018;UNII-XN4TL6M50Z;Lunacalcipol [USAN];Lunacalcipol [USAN:INN];XN4TL6M50Z;CTA 018;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulfonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-(1S,3R)-25-nor-25-t-Butylsulfonyl-9,10-seco-5,7,10(19),16,23- cholestapentaene-1,3-diol;1,3-Cyclohexanediol, 5-((2E)-2-((3aS,7aS)-1-((1R,3E)-4-((1,1-dimethylethyl)sulfonyl)-1- methyl-3-buten-1-yl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4- ylidene)ethylidene)-4-methylene-, (1R,3S,5Z)-;Lunacalcipol (USAN/INN);LUNACALCIPOL [INN];D00DYK;LUNACALCIPOL [WHO-DD];CHEMBL2105705;GTPL11382;CHEBI:177662;CTA018/MT2832;BDBM50023361;AKOS040752736;MT-2832;D09928;Q27293916;Lunacalcipol (intravenous, secondary hyperparathyroidism);CTA-018 (intravenous, secondary hyperparathyroidism), Cytochroma;Lunacalcipol (intravenous, secondary hyperparathyroidism), Cytochroma;CYP24 inhibitors (intravenous, secondary hyperparathyroidism), Johns Hopkins/Cytochroma;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-24-((1,1-Dimethylethyl)sulfonyl)-9,10-secochola-5,7,10(19),16,23- pentaene-1alpha,3beta-diol](http://www.lookchem.com/300w//file1.lookchem.com/cas/2024/01/08/250384-82-8.jpg)